Tardive Dyskinesia

Latest News

tardive dyskinesia
Deutetrabenazine Shows Long Term Efficacy and Safety in Patients with Tardive Dyskinesia

September 24th 2024

A new analysis from a 3-year open-label extension study revealed that treatment with deutetrabenazine was associated with long term improvement of symptoms of tardive dyskinesia.

Rakesh Jain
Why Clinicians Should Be Excited About Austedo XR

June 3rd 2024

tardive dyskinesia
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia and Huntington Disease

May 30th 2024

tardive dyskinesia
Managing Tardive Dyskinesia: New Data from Phase 3 Study of Ingrezza

May 22nd 2024

Here are highlights from the third day of this year’s APA Annual Meeting.
The 2024 APA Annual Meeting: Monday, May 6

May 7th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.